Global Mice Model Market to reach US$1.7 bn till 2023, Propelled by Growing Applications of Mice Models

Studies show that mice models have been used in medical research activities since the 16th century. In the past 25 years, 80% of medical discoveries and biomedical research has been achieved through research on mice. The use of mice models is expected to grow rapidly in the near future.

Global Mice Model Market Report: http://www.mrrse.com/mice-model-market

According to a market research report available on Market Research Reports Search Engine (MRRSE), the global mice model market stood at US$1 bn in 2014 and is expected to reach US$1.7 bn by 2023 at a 6.40% CAGR. There has been a rapid growth in the use of mice models to study human diseases in the recent past. Mice models have become indispensable for researchers experimenting with different treatment strategies. Growth in the number of applications of mice models is expected to propel the global mice model market till 2023.

Growing Applications of Mice Models for Different Treatments

The use of mice models in the discovery of new medicines has been seen since many decades. Mice models are popularly used for studying and evaluating various treatments, such as cancer, neurological disorders, metabolic anomalies, and cardiovascular diseases. Some of the more common drug discovery mice model applications are the development of therapeutic strategies for treating human diseases, drug screening, and screening of toxicity and safety of use of drugs and target identification, and validation. Factors such as rising worries about animal cruelty, animal safety ethics, and stringent regulatory framework are expected to negatively impact the growth of the global mice model market during the forecast period.

The global mice model market is segmented on the basis of geography, type of model, services, and application. Based on the type of model, the global mice model market is divided into transplantation mouse, knockout, spontaneous mouse, hybrid, transgenic, inbred, outbred, and surgically modified sectors. The inbred type of model led the global mice model market in 2014 with a 29.6% share. The mice model service market is predicted to rise at a 7.30% CAGR till 2023.

By application, the global mice model market is classified into the central nervous system, cardiovascular, metabolism, regulation, diabetes, and oncology. Some of the services offered to end-users are cryopreservation and cryorecovery, model in-licensing, genetic testing, and quarantine services. With mice sharing 99% of their genes with humans, new possibilities for genetic testing are expected to propel the global mice model market.

Request a Sample Copy of the Report @ http://www.mrrse.com/sample/353


North America to represent new Opportunities for Mice Mode Experiments
Geographically the global mice model market is segmented into Asia Pacific, Europe, North America, the Middle East and North Africa, Latin America, and Rest of the World. The global mice model market was dominated by North America in 2014. Developments in biologics and drugs are expected to propel the global mice model market during the forecast period. The Asia Pacific market for mice models is predicted to be the fastest growing market by 2023. The global mice model market is well-spread with leading companies covering all major regions across the globe. Some of the leading companies in the global mice model market are Charles River Laboratories, Deltagen, Inc., Harlan Laboratories Inc., Taconic Bioscience Inc., SAGE Labs, TransGenic Inc., Crescendo Biologics Limited, genOway S.A., ImmunoGenes AG, Lexicon Pharmaceuticals, and The Jackson Laboratory.